It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Congenital hyperinsulinism (CH) is a rare disease, characterized by severe hypoglycemia induced by inappropriate insulin secretion from pancreatic beta-cells in neonate and infant. Hirschsprung’s disease (HD) is also a rare disease in which infants show severe bowel movement disorder. We herein report an extremely rare case of combined CH and HD.
Case presentation
The patient was a full-term male infant who showed poor feeding, vomiting, and hypotonia with lethargy on the day of birth. He was transferred to tertiary hospital after a laboratory analysis revealed hyperinsulinemic hypoglycemia. The patient showed remarkable abdominal distension without meconium defecation. An abdominal X-ray showed marked dilatation of the large bowel. He was diagnosed with CH (nesidioblastosis) associated with suspected HD. He was initially treated with an intravenous infusion of high-dose glucose with the intermittent injection of glucagon. This was successfully followed by treatment with diazoxide and octreotide (a somatostatin analog). At 8 months of age, HD was confirmed by the acetylcholinesterase staining of a rectal mucosal biopsy specimen, and a transanal pull-through operation was performed to treat HD. At 14 months of age, subtotal pancreatectomy was performed for the treatment of focal CH located in the pancreatic body. His postoperative course over the past 12 years has been uneventful without any neurologic or bowel movement disorders.
Conclusions
Although it is extremely rare for CH to be associated with HD, associated HD should be considered when a patient with CH presents severe constipation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Shono Kumiko 1 ; Hashimoto Yoshiko 1 ; Taguchi Shohei 2 ; Masuda Masanori 3 ; Kastumi, Muramori 4 ; Taguchi Tomoaki 5 1 National Hospital Organization, Kokura Medical Center, Department of Pediatric Surgery, Kitakyushu, Japan (GRID:grid.470350.5)
2 Kitakyushu Medical Center, Department of Pediatric Surgery, Kitakyushu, Japan (GRID:grid.470350.5)
3 Saga-ken Medical Center Koseikan, Department of Pathology, Saga, Japan (GRID:grid.470350.5)
4 Saga-ken Medical Center Koseikan, Department of Pediatric Surgery, Saga, Japan (GRID:grid.470350.5)
5 Kyushu University, Department of Pediatric Surgery, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849)




